0 Комментарии
0 Поделились
2Кб Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Войдите, чтобы отмечать, делиться и комментировать!
-
Companion Diagnostics Market Trends in Molecular Biomarker TestingThe companion diagnostics market is becoming an increasingly important link between diagnosis and treatment. Instead of asking only whether a disease is present, modern healthcare is increasingly asking a more specific question: which therapy is most appropriate for this patient? That change is reshaping the role of diagnostics. A biomarker can now influence whether a targeted drug is...0 Комментарии 0 Поделились 263 Просмотры 0 предпросмотр
-
Advances in Biomarker-Based Diagnostics Are Transforming the Calprotectin Testing IndustryThe increasing prevalence of inflammatory bowel disease (IBD), growing demand for non-invasive diagnostic tools, and rising awareness of early gastrointestinal disease detection are driving the growth of the calprotectin testing market. However, the market also faces several challenges. High testing costs, limited reimbursement in certain healthcare systems, variability in test...0 Комментарии 0 Поделились 264 Просмотры 0 предпросмотр
-
Biomarker Detection Kits and Multiplex Immunoassays: Revolutionizing Clinical DiagnosticsIn the realm of clinical diagnostics, few areas have seen as much progress and innovation as the development of biomarker detection kits. The evolution of these kits has been a game-changer, transforming what was once a time-consuming, sample-intensive process into a highly efficient, information-rich analytical approach. Central to this transformation are Biomarker Detection Kits ,...0 Комментарии 0 Поделились 314 Просмотры 0 предпросмотр
-
Cystatin C Testing Market: Renal Biomarker Testing and Clinical Diagnostics to 2034The Cystatin C Testing Market is gaining importance as healthcare providers increasingly seek sensitive, reliable biomarkers to evaluate kidney function. Cystatin C is a low-molecular-weight protein produced by cells throughout the body and filtered by the kidneys, making it useful for assessing glomerular filtration. Compared with conventional kidney-function assessments, cystatin C testing...0 Комментарии 0 Поделились 171 Просмотры 0 предпросмотр
-
Europe Ovarian Cancer Diagnostics Market Size, Share, Biomarker Trends and Strategic Forecast 2032"Executive Summary Europe Ovarian Cancer Diagnostics Market Size and Share Analysis Report Data Bridge Market Research analyses that the market is growing with a CAGR of 6.5% in the forecast period of 2023 to 2030 and is expected to reach USD 3,093.84 million by 2030 from USD 1,874.16 million in 2022. the Europe Ovarian Cancer Diagnostics Market analysis report, the strength and...0 Комментарии 0 Поделились 912 Просмотры 0 предпросмотр
-
Lung Cancer Diagnostics Kit Market – Advancing Early Detection Through Molecular and Biomarker TestingMarket Overview The lung cancer diagnostics kit market is expanding as clinical laboratories increasingly adopt molecular and biomarker-based testing to enable earlier, more precise lung cancer detection and treatment selection. Diagnostic kits spanning liquid biopsy, genetic mutation panels, and protein biomarker assays support both initial diagnosis and ongoing treatment monitoring. The Lung...0 Комментарии 0 Поделились 374 Просмотры 0 предпросмотр
-
Renal Biomarker Market: Early Detection Trends in AKI and CKD, AI-Enabled Diagnostics, and Clinical Research Applications"Future of Executive Summary Renal Biomarker Market: Size and Share Dynamics Data Bridge Market Research analyses that the renal biomarker market is expected to reach the value of USD 508.34 million by the year 2029, at a CAGR of 7.70% during the forecast period. A DBMR team of experts and professionals from a number of streams and verticals bring along crucial tried-and-tested skills,...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
Adrenal Cancer Diagnostics Market Size and Revenue Forecast to 2030According to the latest report published by Data Bridge Market Research, the Adrenal Cancer Diagnostics Market Data Bridge Market Research analyses that the adrenal cancer diagnostics market which was USD 130 billion in 2022, is expected to reach USD 207.20 billion by 2030, at a CAGR of 6% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
Adrenal Cancer Diagnostics Market Size, Share and Trends Forecast to 2030According to the latest report published by Data Bridge Market Research, the Adrenal Cancer Diagnostics Market Data Bridge Market Research analyses that the adrenal cancer diagnostics market which was USD 130 billion in 2022, is expected to reach USD 207.20 billion by 2030, at a CAGR of 6% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as...0 Комментарии 0 Поделились 10Кб Просмотры 0 предпросмотр
-
Adrenal Cancer Diagnostics Market Size, Share, and Forecast to 2030According to the latest report published by Data Bridge Market Research, the Adrenal Cancer Diagnostics Market Data Bridge Market Research analyses that the adrenal cancer diagnostics market which was USD 130 billion in 2022, is expected to reach USD 207.20 billion by 2030, at a CAGR of 6% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as...0 Комментарии 0 Поделились 4Кб Просмотры 0 предпросмотр
-
Asia-Pacific Genetic Testing Market Size, Share and Forecast Report to 2029According to the latest report published by Data Bridge Market Research, the Asia-Pacific Genetic Testing Market Asia-Pacific genetic testing market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 16.3% in the forecast period of 2022 to 2029 and is expected to reach USD 11,255.30...0 Комментарии 0 Поделились 11Кб Просмотры 0 предпросмотр
-
Asia-Pacific Multiplex Assays Market Size and Revenue Forecast to 2032According to the latest report published by Data Bridge Market Research, the Asia-Pacific Multiplex Assays Market The Asia-Pacific multiplex assays market size was valued at USD 750.50 million in 2024 and is expected to reach USD 1,562.55 million by 2032, at a CAGR of 9.6% during the forecast period Attaining maximum return on investment (ROI) is...0 Комментарии 0 Поделились 3Кб Просмотры 0 предпросмотр
-
Asia-Pacific Multiplex Assays Market Size, Share and Trends Forecast to 2032According to the latest report published by Data Bridge Market Research, the Asia-Pacific Multiplex Assays Market The Asia-Pacific multiplex assays market size was valued at USD 750.50 million in 2024 and is expected to reach USD 1,562.55 million by 2032, at a CAGR of 9.6% during the forecast period The market research studies of Asia-Pacific Multiplex...0 Комментарии 0 Поделились 3Кб Просмотры 0 предпросмотр
-
Autoimmune Disease Diagnostics Market Sees Momentum From Personalized TestingThe autoimmune disease diagnostics market is gaining momentum as the growing burden of autoimmune disorders increases demand for early, accurate, and efficient disease detection. The market was valued at USD 6.1 billion in 2025 and is estimated to reach USD 6.4 billion in 2026. It is projected to expand to USD 9.6 billion by 2033, registering a CAGR of 5.8% from 2026 to 2033. The increasing...0 Комментарии 0 Поделились 83 Просмотры 0 предпросмотр
-
Biomarker-Based Testing Gains Importance Across the Cancer Care JourneyThe cancer biomarkers market is entering a period of strong expansion as rising cancer cases, increasing emphasis on early diagnosis, and growing adoption of personalized treatment continue to reshape oncology care. According to Grand View Research, the market size was valued at USD 26.9 billion in 2025 and is projected to increase from USD 29.9 billion in 2026 to USD 65.3 billion by 2033,...0 Комментарии 0 Поделились 882 Просмотры 0 предпросмотр
-
Clinical LC-MS Market to Reach USD 1.69 Billion by 2031 | CAGR 7.4%According to a newly published market research report by 24LifeSciences, global clinical LC-MS market was valued at USD 1.03 billion in 2024 and is projected to reach USD 1.69 billion by 2031, growing at a compound annual growth rate (CAGR) of 7.4% during the forecast period 2025-2031. Liquid chromatography-mass spectrometry (LC-MS), clinically known as the gold standard for clinical...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
Companion Diagnostics Market Could Double as Targeted Therapy Adoption RisesThe companion diagnostics market is becoming increasingly important as healthcare moves from broad treatment approaches toward precision medicine and biomarker-guided therapies. The market was valued at USD 9.6 billion in 2025 and is projected to grow from USD 10.3 billion in 2026 to USD 20.1 billion by 2033, registering a CAGR of 10.1% from 2026 to 2033. Increasing demand for precision...0 Комментарии 0 Поделились 106 Просмотры 0 предпросмотр
Расширенные страницы
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek
Bengali